Confirmed Speakers:

• Robert Naviaux, MD, Ph.D.
  Founder of the UCSD Mitochondrial and Metabolic Disease Center (MMDC). He discovered the cause of Alpers syndrome, and part of the team that reported the first mitochondrial DNA mutation to cause genetic forms of autism.
  
  
• Mark Tarnopolsky, BPE, MD, Ph.D.
  Professor of Pediatrics and Medicine, McMaster Children’s Hospital / Hamilton Health Sciences Foundation Chair in Neuromuscular Disorders, Division Head of Neuromuscular and Neurometabolic Disorders, McMaster Children’s Hospital, Canada and Founder, CEO & CSO, Exerkine Corporation.
  
  
• Elissa Epel, Ph.D.
  Professor and Vice Chair in the Department of Psychiatry, at University of California, San Francisco. Director of the Aging, Metabolism, and Emotions Center, Associate Director of the Center for Health and Community and the NIDDK UCSF NORC, member of the National Academy of Medicine, and past President of the Academy of Behavioral Medicine Research and Co-Chair of the Mind and Life Institute Steering Council.
  
  
• Andrew Dillin, Ph.D.
  Professor, University of California at Berkeley, Departments of Molecular and Cell Biology, Immunology and Molecular Medicine. Howard Hughes Medical Investigator and the Thomas and Stacey Siebel Distinguished Chair in Stem Cell Research at the Department of Molecular and Cell Biology.
  
  
• Phillip Dumesic, MD. Ph.D.
  Assistant Professor in the Diabetes Center at University of California, San Francisco. His research has been supported by the Damon Runyon Cancer Research Foundation and the National Institutes of Health.